Tackling the world’s biggest killer
A healthy heart for a healthy life
Cardiovascular diseases are the top cause of mortality globally, responsible for nearly one in three deaths each year. They encompass conditions such as heart attack, stroke and heart failure, which result from damage to the heart and blood vessels. Despite advances in prevention and treatment, cardiovascular diseases continue to burden healthcare systems and communities, with global direct and indirect costs predicted to total over one trillion US dollars by 2030 (1). We urgently need new solutions to better protect heart and vascular health, and improve length and quality of life worldwide.
1. White Paper for Circulatory Health, 2025, Global Coalition for Circulatory Health
Transforming research into real-world solutions
The QUT Centre for Biomedical Technologies is tackling cardiovascular diseases to improve prevention, prediction, diagnosis and treatment.
We discover, develop and deliver the next frontier of biomedical technologies, including the MiniPump for heart-failure patients, for better patient treatment and quality of life.
Our researchers are:
-
pioneering an artificial heart device for patients with preserved ejection fraction
-
developing computer and “patient-on-a-bench” models to investigate artificial heart performance
-
co-directing the $50M Artificial Heart Frontiers Program, providing national leadership in translation
-
designing more accurate 3D-printed blood-flow models to investigate plaque build-up in stroke
-
advancing ultrasound imaging to assess effects of posture and exercise on blood-flow dynamics
-
building point-of-care diagnostics to predict risk of blood-vessel rupture
-
inspiring future cardiac innovators through creation of the global Heart Hackathon
Our researchers
Capability statement
Download the flyer and read more
